Profile
Patrick Loustau formerly worked at Bristol Myers Squibb Co., as Senior Vice President-Global Commercialization in 2014, Novo Nordisk A, as Senior VP-Global Marketing & Medical Affairs in 2010, and Zafgen, Inc., as President from 2014 to 2016.
Mr. Loustau received his graduate degree from Université de Paris XI Paris Sud.
Former positions of Patrick Loustau
| Companies | Position | End |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | President | 18/07/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/03/2014 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 30/06/2010 |
Training of Patrick Loustau
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Private companies | 2 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
- Stock Market
- Insiders
- Patrick Loustau
